ABCG2 and lung cancer: The reversal effect of CC-671 is mainly due to the inhibition of ABCG2 drug efflux activity, resulting in an increase in intracellular chemotherapeutic drug levels, which can improve the efficacy of chemotherapeutic drugs on ABCG2-overexpressing lung cancer cells (Wu et al. 2020).